Merck KGaA

Industry / private company


Location: Darmstadt, Germany (DE) DE

ISNI: 0000000106727022

ROR: https://ror.org/04b2dty93

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Unraveling Complexity: A Strategy for the Characterization of Anisotropic Core Multishell Nanoparticles (2020) Lin W, Greve C, Härtner S, Götz K, Walter J, Wu M, Rechberger S, et al. Journal article Evaluating the structural effects of intra-articular sprifermin on cartilage and non-cartilaginous tissue alterations, based on sqMRI assessment over 2 years (2020) Roemer F, Kraines J, Aydemir A, Wax S, Hochberg MC, Crema MD, Guermazi A Journal article Expert opinion consensus on recommendations for treating relapsing multiple sclerosis with cladribine tablets in daily clinical practice (2020) Sorensen PS, Centonze D, Giovannoni G, Montalban X, Selchen D, Vermersch P, Wiendl H, et al. Conference contribution Long-term disease stability assessed by the expanded disability status scale in patients treated with Cladribine tablets in the CLARITY and CLARITY extension studies (2019) Giovannoni G, Comi G, Rammohan K, Rieckmann P, Vermersch P, Dangond F, Keller B, Jack D Conference contribution Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study (2019) Giovannoni G, Sorensen PS, Cook S, Rammohan KW, Rieckmann P, Comi G, Dangond F, et al. Journal article INTERSITE COMPARISON AND TEST-RETEST RELIABILITY OF CARTILAGE THICKNESS AND COMPOSTIONAL ANALYSIS IN THE APPROACH STUDY - A 2-YEAR MULTICENTER EUROPEAN EXPLORATORY STUDY FOR PHENOTYPE CHARACTERIZATON OF KNEE OSTEOARTHRITIS (2019) Eckstein F, Maschek S, Bay-Jensen A, Boere J, Hussaarts L, Ladel C, Lalande A, et al. Conference contribution Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis (2019) Comi G, Cook S, Giovannoni G, Rieckmann P, Sorensen PS, Vermersch P, Galazka A, et al. Journal article Oxidation-Induced Destabilization of Model Antibody-Drug Conjugates (2019) Bücheler J, Winzer M, Weber C, Gieseler H Journal article Alteration of Physicochemical Properties for Antibody-Drug Conjugates and Their Impact on Stability (2019) Bücheler J, Winzer M, Weber C, Gieseler H Journal article, Review article Cetuximab in combination with platinum-based chemotherapy or radiotherapy in patients with recurrent and/or metastatic SSCHN in clinical routine: Updated interim results of the prospective SOCCER study (2018) Hecht M, Hahn D, Wolber P, Hautmann M, Reichert D, Weniger J, Belka C, et al. Conference contribution
1 2 3 4 5